Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993-Reference-Cited by-同舟云学术

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

Published:2010-01 Issue:1 Volume:148 Page:80-89
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Patel Bella,Rai Lena,Buck Georgina,Richards Sue M.,Mortuza Yeasmin,Mitchell Wayne,Gerrard Gareth,Moorman Anthony V.,Duke Veronique,Hoffbrand A. Victor,Fielding Adele K.,Goldstone Anthony H.,Foroni Letizia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07941.x/fullpdf

Reference31 articles.

1. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group;Attal;Blood,1995

2. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia;Bruggemann;Blood,2006

3. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer â Childhood Leukemia Cooperative Group;Cave;The New England Journal of Medicine,1998

4. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL;Chim;British Journal of Haematology,1996

5. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia;Coustan-Smith;Blood,2000

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of ALL in adults: 2024 ELN recommendations from a European expert panel;Blood;2024-05-09

2. Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols;Leukemia;2024-01-05

3. ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia;Hematological Oncology;2024-01

4. Minimal Residual Disease Detection Using Gene Scanning Analysis, Fluorescent Fragment Analysis, and Capillary Electrophoresis for IgH Rearrangement in Adult B-Lineage Acute Lymphoblastic Leukemia: A Cross-Sectional Study;CELL J;2023

5. Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia;Diagnostics;2022-12-21